A 1-day regimen of nitrofurantoin is markedly less effective than a 7-day regimen to treat asymptomatic bacteriuria in pregnant women.
A 1-day regimen of the antibiotic nitrofurantoin is markedly less effective than a 7-day regimen to treat asymptomatic bacteriuria in pregnant women, according to research published in the February issue of Obstetrics & Gynecology.
Pisake Lumbiganon, MD, of Khon Kaen University in Thailand, and colleagues compared the 1-day versus 7-day antibiotic regimen in a multicenter, double-blind non-inferiority study that randomized 778 pregnant women with asymptomatic bacteriuria to receive either dosage schedule. Nearly half of infections were due to Escherichia coli. The primary study outcome was bacteriologic cure at day 14.
The rates of bacteriologic cure at day 14 were 75.7% and 86.2% for the 1-day and 7-day regimens, respectively, the investigators found. The researchers report that this 10.5% difference indicated that the 1-day regimen was significantly less effective compared with the 7-day regimen. In addition, preterm delivery and low birthweight were more frequent in patients receiving the 1-day regimen, leading to significant decreases in mean birthweight and mean gestational age at delivery, the report indicates.
Lumbiganon P, Villar J, Laopaiboon M, et al. One-day compared with 7-day nitrofurantoin for asymptomatic bacteriuria in pregnancy: A randomized controlled trial. Obstet Gynecol. 2009;113:(Pt. 1):339-345. doi: 10.1097/AOG.ob013e318195c2a2
Multicomponent intervention boosts quality of life in overactive bladder patients
March 15th 2024A recent study reveals the efficacy of a cognitive behavior therapy program, showcasing significant improvements in health-related quality of life among women grappling with moderate to severe overactive bladder.
Read More
Optimizing pain management post urogynecologic surgery with restrictive opioid protocol
March 14th 2024A recent study suggests that restrictive opioid prescribing protocols post-urogynecologic surgery are as effective as standard protocols, emphasizing the importance of multimodal analgesia and outpatient follow-up for patient satisfaction.
Read More
Study finds no increased stress urinary incontinence recurrence risk from childbirth
March 11th 2024A recent meta-analysis challenged common clinical assumptions, finding no increased risk of stress urinary incontinence recurrence or need for reoperation after subsequent pregnancy and childbirth following a midurethral sling procedure.
Read More
Cefepime–Taniborbactam outperforms meropenem in treating complicated UTI
February 15th 2024A recent study demonstrated the superior efficacy of cefepime–taniborbactam over meropenem for managing complicated urinary tract infections, suggesting a promising treatment option amid rising antibiotic resistance challenges.
Read More